Taken from The Proceedings of The XXI ISPIM Conference 2010 Bilbao, Spain - 6-9 June 2010 ISBN 978-952-214-926-8. The full paper and/or presentation is available to current members of ISPIM who must log in to the Members Section of http://www.ispim.org to gain access.
The uptake and diffusion of innovations: a case of stem cell technology
Recent stem cell-related technologies, human somatic and pluripotent stem cells in particular, have been markedly progressing and being focused for an origin of medical and pharmaceutical innovations. However, many issues still remain to realize accomplishments of basic research and even strategy for technology development has yet to be sufficiently developed. In this report we attempted to extract current issues regarding formation and application of intellectual properties by looking at the state of patent landscape and also tested a successful business development approach through cases studies on two representative Japan-based bio start-up companies. We found limitation of the pro-patent approaches for the embryonic and induced pluripotent stem cell business and confirmed a shift to pro-innovation strategy by acquiring variable means including know-how, tangible asset and external network to protect rights. As per standardization strategy a stepwise model based on internal integrality ahead of external modularity was proposed.